TerrAscend Corp. (TSX:TSND)
0.8500
-0.0100 (-1.16%)
Feb 11, 2026, 2:58 PM EST
TerrAscend Market Cap
TerrAscend has a market cap or net worth of CAD 264.27 million as of February 11, 2026. Its market cap has increased by 17.59% in one year.
Market Cap
264.27M
Enterprise Value
568.92M
Revenue
417.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.85
Market Cap Chart
Since May 3, 2017, TerrAscend's market cap has increased from 35.38M to 264.27M, an increase of 647.00%. That is a compound annual growth rate of 25.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 276.56M | -8.18% |
| Dec 31, 2025 | 301.20M | 12.48% |
| Dec 31, 2024 | 267.77M | -57.63% |
| Dec 29, 2023 | 632.00M | 57.35% |
| Dec 30, 2022 | 401.64M | -72.92% |
| Dec 31, 2021 | 1.48B | -24.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 507.12M |
| Cipher Pharmaceuticals | 365.06M |
| Aurora Cannabis | 275.61M |
| Organigram Global | 255.41M |
| Cannara Biotech | 185.71M |
| Auxly Cannabis Group | 170.88M |
| BioSyent | 163.43M |
| Cardiol Therapeutics | 160.86M |